2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
80
Head and Neck Neoplasms
72
Nasopharyngeal Carcinoma
61
Prostatic Neoplasms
51
Oropharyngeal Neoplasms
30
Carcinoma, Non-Small-Cell Lung
27
Rectal Neoplasms
23
Carcinoma, Squamous Cell
23
Breast Neoplasms
23
Glioblastoma
22
Uterine Cervical Neoplasms
18
Carcinoma
18
Neoplasm Metastasis
16
Brain Neoplasms
16
Nasopharyngeal Neoplasms
15
Pancreatic Neoplasms
14
Lung Neoplasms
13
Gliosarcoma
13
Glioma
13
Esophageal Neoplasms
13
Radiation Injuries
12
Mouth Neoplasms
12
Laryngeal Neoplasms
12
Esophageal Squamous Cell Carcinoma
12
Astrocytoma
12
Tongue Neoplasms
11
Hypopharyngeal Neoplasms
11
Sarcoma
10
Neoplasms
10
Salivary Gland Neoplasms
8
Interventions
Morphine
16
Oxycodone
14
Fentanyl
10
Methadone
7
nabiximols
5
Lidocaine
5
Acetaminophen
5
resiniferatoxin
4
Hydromorphone
4
Ethanol
4
Acupuncture Therapy
4
Transcutaneous Electric Nerve Stimulation
3
Buprenorphine
3
Transcranial Direct Current Stimulation
2
Tapentadol
2
Surveys and Questionnaires
2
Standard of Care
2
Sodium Bicarbonate
2
Radiosurgery
2
Radiofrequency Ablation
2
Pharmaceutical Services
2
Naloxone
2
Ketamine
2
Electroacupuncture
2
Dronabinol
2
Control Groups
2
Analgesics, Opioid
2
6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine
2
tanezumab
1
rofecoxib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cancer Pain
×
Radiotherapy, Intensity-Modulated
×
Clear all
NCT04595032
2024-11-07
MAMETIC
National Cancer Institute, Naples
Completed
3,234 enrolled